The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
106783562 10678356 2 F 20160803 20141223 20160813 EXP US-INDICUS PHARMA-000284 INDICUS HAROON N, RAZA SM, BHAT ZY. HYPOMAGNESEMIA AND CHEMOTHERAPY, DIAGNOSTIC DILEMMA, AND TREATMENT CHALLENGE: CASE REPORT AND LITERATURE REVIEW. AM J THER. 2014 DEC 1. 63.00 YR F Y 0.00000 20160813 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
106783562 10678356 1 PS METFORMIN METFORMIN HYDROCHLORIDE 1 U 79148
106783562 10678356 2 SS AVASTIN BEVACIZUMAB 1 N 0
106783562 10678356 3 SS IRINOTECAN IRINOTECAN 1 6 CYCLES N 0
106783562 10678356 4 SS XELODA CAPECITABINE 1 U 0
106783562 10678356 5 SS FLUOROURACIL. FLUOROURACIL 1 N 0
106783562 10678356 6 SS FOLINIC ACID LEUCOVORIN 1 N 0
106783562 10678356 7 SS LANSOPRAZOLE. LANSOPRAZOLE 1 U 0
106783562 10678356 8 C LIPITOR ATORVASTATIN CALCIUM 1 0
106783562 10678356 9 C ZOFRAN ONDANSETRON HYDROCHLORIDE 1 0
106783562 10678356 10 C MECLIZINE MECLIZINE HYDROCHLORIDE 1 0
106783562 10678356 11 C ZOLPIDEM ZOLPIDEMOLPIDEM TARTRATE 1 0
106783562 10678356 12 C ERGOCALCIFEROL. ERGOCALCIFEROL 1 0
106783562 10678356 13 C AMITRIPTYLINE AMITRIPTYLINE 1 0
106783562 10678356 14 C HYDROCODONE HYDROCODONE 1 0
106783562 10678356 15 C CITALOPRAM CITALOPRAM HYDROBROMIDE 1 0
106783562 10678356 16 C ZANTAC RANITIDINE HYDROCHLORIDE 1 0
106783562 10678356 17 C LORAZEPAM. LORAZEPAM 1 0
106783562 10678356 18 C METOPROLOL. METOPROLOL 1 0
106783562 10678356 19 C LOPERAMIDE LOPERAMIDE 1 0
106783562 10678356 20 C CELECOXIB. CELECOXIB 1 0
106783562 10678356 21 C BENADRYL DIPHENHYDRAMINE HYDROCHLORIDE 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
106783562 10678356 1 Product used for unknown indication
106783562 10678356 2 Colon cancer metastatic
106783562 10678356 3 Colon cancer metastatic
106783562 10678356 4 Colon cancer metastatic
106783562 10678356 5 Colon cancer metastatic
106783562 10678356 6 Colon cancer metastatic
106783562 10678356 7 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
106783562 10678356 HO
106783562 10678356 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
106783562 10678356 Alopecia
106783562 10678356 Diarrhoea
106783562 10678356 Hypomagnesaemia
106783562 10678356 Malabsorption

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
106783562 10678356 2 201210 0
106783562 10678356 3 201105 0
106783562 10678356 5 201105 0
106783562 10678356 6 201105 0